AAS
RMD icon

Ameritas Advisory Services’s ResMed RMD Stock Holding History

Ameritas Advisory Services’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-133
Closed -$36.3K – 1862
2025
Q3 		$36.3K Sell
133
-190
-59% -$51.9K ﹤0.01% 1208
2025
Q2 		$83.3K Buy
+323
New +$77K ﹤0.01% 1069
2023
Q2 		– Sell
-344
Closed -$75.6K – 2116
2023
Q1 		$75.6K Buy
+344
New +$74.6K ﹤0.01% 1106

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Ameritas Advisory Services's RMD Position: Q4 2025 in Review

Ameritas Advisory Services sold out of ResMed (RMD) in Q4 2025, closing a stake of 133 shares — an estimated $36.3K sold.

Ameritas Advisory Services first reported a position in RMD in Q1 2023 and held it in 3 quarters. The position peaked at $83.3K in Q2 2025. 948 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

  • Ameritas Advisory Services reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
  • Ameritas Advisory Services sold 133 ResMed shares in Q4 2025, an estimated $36.3K.
  • Ameritas Advisory Services first reported a position in ResMed in Q1 2023 and held it in 3 quarters.
  • Ameritas Advisory Services's ResMed position peaked at $83.3K in Q2 2025.
  • 948 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on Ameritas Advisory Services's 13F filing for Q4 2025, filed 4 Feb 2026.